HIV AIDS: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 66: Line 66:


==Treatment==
==Treatment==
[[HIV prophylaxis#Pre-exposure prophylaxis|Pre-exposure prophylaxis]] | [[HIV prophylaxis#Managing occupational exposure to HIV|Post-exposure prophylaxis]] | [[AIDS medical therapy|Medical Therapy]] | [[AIDS medical therapy treatment naive patients|Treatment naive patients]] | [[AIDS medical therapy#Patient monitoring during antiretroviral therapy|Monitoring during ART]] | [[AIDS surgery|Surgery]] | [[AIDS primary prevention|Primary Prevention]] | [[AIDS secondary prevention|Secondary Prevention]] | [[Antiretroviral therapy in pregnancy]] | [[HIV/AIDS patient nutrition|Importance of nutrition in a HIV/AIDS patient]] | [[HIV drug resistance|Drug Resistance]] | [[AIDS medical therapy treatment naive patients#3) Cost of therapy|Cost of therapy]]
'''Medical Therapy'''
 
[[HIV prophylaxis#Pre-exposure prophylaxis|Pre-exposure prophylaxis]] | [[HIV prophylaxis#Managing occupational exposure to HIV|Post-exposure prophylaxis]] | [[AIDS medical therapy|Medical Therapy]] | [[AIDS medical therapy treatment naive patients|Treatment naive patients]] | [[AIDS medical therapy#Patient monitoring during antiretroviral therapy|Monitoring during ART]]
 
'''Surgical Therapy'''
 
[[AIDS surgery|Surgery]]
 
'''Prevention'''
 
[[AIDS primary prevention|Primary Prevention]] | [[AIDS secondary prevention|Secondary Prevention]]
 
'''Special Topics'''
 
[[Antiretroviral therapy in pregnancy]] | [[HIV/AIDS patient nutrition|Importance of nutrition in a HIV/AIDS patient]] | [[HIV drug resistance|Drug Resistance]] | [[HIV resistance testing]] | [[AIDS medical therapy treatment naive patients#3) Cost of therapy|Cost of therapy]]


==[[AIDS landmark trials|Landmark Trials/Studies]]==
==[[AIDS landmark trials|Landmark Trials/Studies]]==

Revision as of 22:55, 30 May 2012

For AIDS Patient Information click here

For information on Human Immunodeficiency Virus click here

Acquired immunodeficiency syndrome (AIDS)
The Red ribbon is a symbol for solidarity with HIV-positive people and those living with AIDS.
ICD-10 B24
ICD-9 042
DiseasesDB 5938

Sexually transmitted diseases Main Page

AIDS Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AIDS from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

HIV Opportunistic Infections

HIV Coinfections

HIV and Pregnancy

HIV Infection in Infants

Diagnosis

Diagnostic Study of Choice

AIDS Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Nutrition
Drug Resistance

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

HIV Vaccine

Case Studies

Case #1

HIV AIDS On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV AIDS

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV AIDS

CDC on HIV AIDS

HIV AIDS in the news

Blogs on HIV AIDS

Directions to Hospitals Treating AIDS

Risk calculators and risk factors for HIV AIDS

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

List of abbreviations used in this article

AIDS: Acquired immune deficiency syndrome
HIV: Human immunodeficiency virus
CD4+: T helper cells
CCR5: Chemokine (C-C motif) receptor 5
CDC: Centers for Disease Control and Prevention
WHO: World Health Organization
PCP: Pneumocystis pneumonia
TB: Tuberculosis
MTCT: Mother-to-child transmission
HAART: Highly active antiretroviral therapy
STI/STD: Sexually transmitted infection/disease

Overview

Classification

Comparison between AIDS & HIV

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Prevention & Prophylaxis

AIDS primary prevention | Pre-exposure prophylaxis | Post-exposure prophylaxis | Prevention in prison | IV Drug abusers | HIV among Sex-workers | Immunocompromised travelers

Causes

Differentiating AIDS from other Diseases

Natural History, Complications & Prognosis

HIV and its cognitive effects | HIV opportunistic infections

HIV & Coinfections: Tuberculosis and HIV coinfection | HIV and tuberculosis coinfection : drug interaction | HIV coifection with Hepatitis C | Hepatitis B with HIV coinfection | HIV associated nephropathy

Diagnosis

History & Symptoms | Physical Examination | Laboratory tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies | HIV testing in Pregnancy | HIV testing in Infants

Treatment

Medical Therapy

Pre-exposure prophylaxis | Post-exposure prophylaxis | Medical Therapy | Treatment naive patients | Monitoring during ART

Surgical Therapy

Surgery

Prevention

Primary Prevention | Secondary Prevention

Special Topics

Antiretroviral therapy in pregnancy | Importance of nutrition in a HIV/AIDS patient | Drug Resistance | HIV resistance testing | Cost of therapy

Landmark Trials/Studies

Guidelines

Centers for Disease Control and Prevention (CDC)

Screening HIV pregnant female & infant | Counseling of pregnant women | Guidelines for initiation of ART | Treatment of HIV-Infected pregnant women | Postpartum follow-up and treatment

Guidelines for pre-exposure prophlaxis in Males having sex with men (MSM)

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

National Institute of Health (NIH)

Diagnosis

Laboratory Monitoring Schedule for Patients Prior to and After Initiation of Antiretroviral Therapy | CD4 T-Cell Count | Plasma HIV RNA Testing | Drug-Resistance Testing | HLA-B*5701 Screening | Coreceptor Tropism Assays

Treatment

Treatment-Naive Patients - Initiating Antiretroviral Therapy | Initial Combination Regimens

Treatment-Experienced Patient - Virologic and Immunologic Failure | Exposure-Response Relationship and Therapeutic Drug Monitoring

Special Patient Populations - Acute HIV Infection | HIV-Infected Women | Older Patient

Coinfections - HIV coinfection with hepatitis b | HIV coinfection with hepatitis c | HIV coinfection with tuberculosis | HIV-associated nephropathy

Related Chapters

Further reading

  • "2007 AIDS epidemic update" (pdf). UNAIDS. Retrieved 2008-03-21.
  • "UNAIDS Annual Report - Making the money work" (pdf). UNAIDS. Retrieved 2008-03-21.
  • "Financial Resources Required to Achieve, Universal Access to HIV Prevention, Treatment Care and Support" (pdf). UNAIDS. Retrieved 2008-03-21.
  • "Practical Guidelines for Intensifying HIV Prevention" (pdf). UNAIDS. Retrieved 2008-03-21.
  • "Antiretroviral Formulations" (pdf). US Department of Health and Human Services. Retrieved 2008-03-21.
  • "Approved Medications to Treat HIV Infection" (pdf). US Department of Health and Human Services. Retrieved 2008-03-21.
  • "The HIV Life Cycle" (pdf). US Department of Health and Human Services. Retrieved 2008-03-21.

External links

back to top

Template:WH Template:WS